The epidemiology of breast cancer

European Clinics in Obstetrics and Gynaecology

Volumn 1, Issue 1, 2005, Pages 24-28

  Lidegaard, Øjvind ^a   Kroman, Niels ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aetiology; Breast cancer; Epidemiology; Hormone therapy; Reproduction

Indexed keywords

EID: 25144475074     PISSN: 16133412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11296-004-0007-9     Document Type: Article

References (31)

1. Ewertz M, Carstensen B (1988) Trends in breast cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 41:46-51
2. Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58:209 women with breast cancer and 101:986 women without the disease. Lancet 358:1389-1399
3. Trichopoulos D (1990) Is breast cancer initiated in utero? Epidemiology 1:95-96
4. Ahlgren M, Sorensen T, Wohlfahrt J, Haflidadottir A, Holst C, Melbye M (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 107:997-1000
5. McCormack VA, Silva IDS, Stavola BLD, Mohsen R, Leon DA, Lithell HO (2003) Fetal growth and subsequent risk of breast cancer: Results from long term follow up of Swedish cohort. BMJ 326:248-253
6. Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5-73
7. Chepko G, Smith GH (1997) Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29:239-253
8. Vatten LJ, Maehle BO, Nilsen TLL, Tretli S, Hsieh C, Trichopoulos D, Stuver SO (2002) Birth weight as a predictor of breast cancer: A case control study in Norway. Br J Cancer 86 89-91
9. Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding. Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50:302 women with breast cancer and 96:973 women without the disease. Lancet 360:187-195
10. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303:767-770
11. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 347:1713-1727
12. Marchbanks PA, McDonald JA, Wilson HG, et al (2002) Oral contraceptivesl and the risk of breast cancer. N Engl J Med 346:2025-2032
13. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G (1999) Mortality associated wit oral contraceptive use: 25 year follow up of cohort of 46:000 women from Royal College of General Practitioners' oral contraception study. BMJ 318:96-100
14. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer, hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer, 108:411 women without breast cancer. Lancet 350:1047-1059
15. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
16. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomised controlled trial. JAMA 288:321-333
17. Women's Health Initiative Steering Committee (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The women's health initiative randomized controlled trial. JAMA 291:1701-1712
18. Collaborative Group on Hormonal Factors in Breast Cancer (2002) Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95 067 women without the disease. Br J Cancer 87:1234-1345
19. Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiool 145:1011-1019
20. Thune I, Brenn T, Lund E, Gaard M (1997) Physical activity and the risk of breast cancer. N Engl J Med 336:1269-1275
21. Freudenheim JL, Marshall JR, Vena JE et al (1996) Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 88:340-348
22. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 96:1152-1560
23. Key TJ, Allen NE, Spencer EA, Travis RC (2003) Nutrition and breast cancer. Breast 12:412-416
24. Lidegaard AP (2004) The influence of birth weight on foetal and maternal outcomes. Thesis, Copenhagen University (available on http://www.dachre.dk)
25. Helm P (1984) Menarche in Denmark from 1830s to 1983 [in Danish]. Ugeskr Laeger 146:3902-3904
26. Olesen AW, Jeune B, Boldsen JL (2001) A continued fall in menarche in Denmark [in Danish]. Ugeskr Laeger 163:5828-31
27. Frommer DJ (1964) Changing age of menopause. BMJ 5405:349-351
28. Flint M (2000) Is there a secular trend in age of menopause? Maturitas 1:133-139
29. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al. (2000) Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
30. Kjøller M, Rasmussen NK (2002) Danish health and morbidity survey 2000 & development since 1987. National Institute of Public Health, Copenhagen
31. Henderson BE, Bernstein L (1991) The international variation in breast cancer rates: An epidemiological assessment. Breast Cancer Res Treat 18 [Suppl 1]:S11-S17